Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1991
+0.0064 (3.32%)
At close: May 19, 2026, 4:00 PM EDT
0.2034
+0.0043 (2.16%)
After-hours: May 19, 2026, 7:58 PM EDT
Gossamer Bio Stock Forecast
GOSS's stock price has decreased by -80.86% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 8 analysts polled by S&P Global, Gossamer Bio stock has a consensus rating of "Hold" and an average price target of $4.36. The average 1-year stock price forecast is 2,089.85% higher than the current stock price, while the lowest is $0.28 (+40.63%) and the highest is $15 (+7,433.90%).
Price Target: $4.36 (+2,089.85%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Gossamer Bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 1 |
| Buy | 3 | 4 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains $0.3 → $0.28 | Sell | Maintains | $0.3 → $0.28 | +40.63% | May 19, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $5 | Strong Buy | Maintains | $10 → $5 | +2,411.30% | Mar 6, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $12 → $3 | Buy | Maintains | $12 → $3 | +1,406.78% | Mar 5, 2026 |
| Wedbush | Wedbush | Buy → Hold Downgrades $6 → $1 | Buy → Hold | Downgrades | $6 → $1 | +402.26% | Feb 24, 2026 |
Financial Forecast
Revenue This Year
24.96M
from 48.47M
Decreased by -48.52%
Revenue Next Year
63.69M
from 24.96M
Increased by 155.22%
EPS This Year
-0.46
from -0.75
EPS Next Year
-0.17
from -0.46
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 49.4M | 128.1M | ||||||
| Avg | 25.0M | 63.7M | ||||||
| Low | n/a | 19.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.8% | 413.3% | ||||||
| Avg | -48.5% | 155.2% | ||||||
| Low | - | -22.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.21 | -0.02 | ||||||
| Avg | -0.46 | -0.17 | ||||||
| Low | -0.77 | -0.42 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.